Hemogenyx Pharmaceuticals Plc (LON: HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 355.10
-7.35 (-2.03%)
Jan 23, 2025, 2:24 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 12.70 million as of January 23, 2025. Its market cap has decreased by -50.89% in one year.
Market Cap
12.70M
Enterprise Value
13.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
355.10
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 12.70M, an increase of 18.92%. That is a compound annual growth rate of 2.40%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.31B |
| Haleon | 33.62B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.72B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |